James Mulay, Director at CG Oncology, Inc. (CGON), sold 45,372 shares at $39.01 ($1.8M) on 2025-09-18, disclosed to the SEC on 2025-09-22.
Scheduled sale ($1.8M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.01 | 19,112 | $746K | 42.1% |
| 2 | $39.01 | 19,112 | $746K | 42.1% |
| 3 | $38.99 | 3,574 | $139K | 7.9% |
| 4 | $38.99 | 3,574 | $139K | 7.9% |
| Total | $39.01 avg | 45,372 | $1.8M | 100% |
| Filing → |
| CGON | SELL | 2026-04-20 | $1.1M | — | Filing → |
| CGON | SELL | 2026-03-17 | $125K | — | Filing → |
| CGON | SELL | 2026-01-13 | $585K | — | Filing → |